PAI Partners Acquires Apleona from EQT for ~€1.6bn

Bain Capital Acquires Apleona from PAI Partners

February 14, 2025

Real Estate

Bain Capital, through a consortium led by its Europe Private Equity team, has agreed to acquire Apleona, the Neu-Isenburg-based European integrated facility management group, from PAI Partners. The deal will support Apleona's continued growth — including European platform expansion, digital transformation and ESG/decarbonisation capabilities — and is subject to customary closing conditions and regulatory approvals.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.

PAI Partners to acquire Nuzoa from Abac Capital

March 24, 2025

Veterinary

PAI Partners, via its PAI Mid-Market Fund, has agreed to acquire Nuzoa, the leading integrated animal health products and services distributor in Iberia, from Abac Capital. PAI plans to accelerate Nuzoa's growth through further consolidation in the fragmented Iberian market, expansion into other European markets and by developing additional vet-focused services such as digital solutions and laboratory diagnostics.

PAI Partners Agrees to Acquire Majority Stake in ECF Group

June 14, 2023

Logistics & Distribution

PAI Partners has made a binding offer to acquire a majority stake in ECF Group from French private equity firm Naxicap Partners, with Naxicap remaining a minority investor alongside management. ECF is an omnichannel B2B distributor of equipment, consumables and hygiene products for hospitality and care professionals, headquartered in Grigny, France (~1,750 employees, ~€760m revenue); PAI intends to accelerate growth organically and via acquisitions to consolidate the fragmented market.

PAI Partners Acquires 67% Stake in VAMED's European Rehabilitation Business from Fresenius

May 2, 2024

Healthcare Services

PAI Partners will acquire a 67% stake in VAMED's pan‑European rehabilitation business from Fresenius, with Fresenius retaining a 33% stake. The carved‑out business operates 67 clinics across multiple European countries, employs around 10,000 staff and will operate as a standalone rehabilitation platform focused on operational excellence and further investment.

EQT Private Equity and Goldman Sachs Asset Management Acquire Parexel from Pamplona Capital Management

July 2, 2021

Healthcare Services

EQT Private Equity (EQT IX) and Goldman Sachs Asset Management's Private Equity business have agreed to acquire Parexel from Pamplona Capital Management for an enterprise value of USD 8.5 billion. Parexel, a global clinical research organization co-headquartered in Durham, North Carolina and Newton, Massachusetts, employs more than 17,000 people and provides outsourced clinical development, regulatory, market access and consulting services to the pharma and biotech industry.